Laboratory operator Quest Diagnostics beat Wall Street estimates for third-quarter profit and revenue on Tuesday, helped by robust demand for its diagnostic tests.
StockNews.com upgraded shares of Quest Diagnostics (NYSE:DGX – Free Report) from a hold rating to a buy rating in a research report released on Thursday morning. Other equities research analysts have ...
Oct 23 - Lab operator Quest Diagnostics (DGX.N), opens new tab said on Wednesday it will launch a test for H5N1 bird flu at the end of October after the U.S. Centers for Disease Control and ...
What Happened: Kuppusamy's recent move involves selling 1,775 shares of Quest Diagnostics. This information is documented in a Form 4 filing with the U.S. Securities and Exchange Commission on ...